Hikari Power’s Aldeyra Therapeutics ALDX Stock Holding History

Hikari Power’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43K	Hold	20,020	–	–	0.01%	43
2026 Q1	$34K	Hold	20,020	–	–	﹤0.01%	51
2025 Q4	$104K	Hold	20,020	–	–	0.01%	63
2025 Q3	$105K	Hold	20,020	–	–	0.01%	63
2025 Q2	$77K	Hold	20,020	–	–	0.01%	63
2025 Q1	$115K	Hold	20,020	–	–	0.01%	60
2024 Q4	$100K	Hold	20,020	–	–	0.01%	59
2024 Q3	$108K	Hold	20,020	–	–	0.01%	62
2024 Q2	$66K	Hold	20,020	–	–	0.01%	62
2024 Q1	$65K	Hold	20,020	–	–	0.01%	63
2023 Q4	$70K	Hold	20,020	–	–	0.01%	64
2023 Q3	$134K	Hold	20,020	–	–	0.01%	62
2023 Q2	$168K	Hold	20,020	–	–	0.02%	60
2023 Q1	$199K	Hold	20,020	–	–	0.02%	62
2022 Q4	$139K	Hold	20,020	–	–	0.01%	61
2022 Q3	$107K	Hold	20,020	–	–	0.01%	62
2022 Q2	$80K	Hold	20,020	–	–	0.01%	64
2022 Q1	$89K	Hold	20,020	–	–	0.01%	65
2021 Q4	$80K	Hold	20,020	–	–	0.01%	64
2021 Q3	$176K	Hold	20,020	–	–	0.02%	62
2021 Q2	$227K	Hold	20,020	–	–	0.02%	64
2021 Q1	$238K	Hold	20,020	–	–	0.03%	60
2020 Q4	$137K	Hold	20,020	–	–	0.02%	65
2020 Q3	$148K	Sell	20,020 -20,000	-50%	-$129K	0.02%	55
2020 Q2	$167K	Sell	40,020 -20,000	-33%	-$73.1K	0.02%	58
2020 Q1	$148K	Sell	60,020 -20,000	-25%	-$90K	0.02%	73
2019 Q4	$465K	Hold	80,020	–	–	0.05%	67
2019 Q3	$422K	Buy	80,020 +35,500	+80%	+$191K	0.05%	76
2019 Q2	$267K	Hold	44,520	–	–	0.03%	87
2019 Q1	$402K	Sell	44,520 -15,670	-26%	-$133K	0.04%	79
2018 Q4	$500K	Sell	60,190 -47,668	-44%	-$488K	0.06%	70
2018 Q3	$1.49M	Hold	107,858	–	–	0.15%	61
2018 Q2	$857K	Hold	107,858	–	–	0.09%	68
2018 Q1	$809K	Hold	107,858	–	–	0.1%	66
2017 Q4	$733K	Hold	107,858	–	–	0.09%	62
2017 Q3	$777K	Hold	107,858	–	–	0.1%	60
2017 Q2	$507K	Buy	107,858 +70,196	+186%	+$323K	0.07%	64
2017 Q1	$188K	Buy	+37,662	New	+$194K	0.03%	64

Other funds holding ALDX

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Hikari Power's ALDX Position: Q2 2026 in Review

Hikari Power held its Aldeyra Therapeutics (ALDX) position steady in Q2 2026 at 20,020 shares worth $43K. The position accounts for 0.01% of the portfolio, ranked #43.

Hikari Power first reported a position in ALDX in Q1 2017 and has held it in 38 quarters since. The position peaked at $1.49M in Q3 2018. 108 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

Hikari Power held 20,020 shares of Aldeyra Therapeutics worth $43K as of Q2 2026.
Hikari Power left its Aldeyra Therapeutics share count unchanged in Q2 2026.
Aldeyra Therapeutics made up 0.01% of Hikari Power's portfolio in Q2 2026, its #43 holding.
Hikari Power first reported a position in Aldeyra Therapeutics in Q1 2017 and has held it in 38 quarters since.
Hikari Power's Aldeyra Therapeutics position peaked at $1.49M in Q3 2018.
108 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Hikari Power's 13F filing for Q2 2026, filed 7 Aug 2026.